Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
J.L. Bainbridge Buys $45 Million in Eli Lilly Stock Despite Price-Pressure Fears
09:55pm, Sunday, 19'th Oct 2025
Florida-based wealth advisory J. L. Bainbridge disclosed a purchase of Eli Lilly and Company valued at approximately $45.6 million for the quarter ended September 30, according to an SEC filing releas
Investment Advisor Goes All-In on Big Pharma Stock to the Tune of $1.07 Billion, According to Recent Filing
07:01pm, Sunday, 19'th Oct 2025
On October 17, 2025, Sapient Capital LLC disclosed a purchase of 259,392 Eli Lilly and Company (LLY -1.94%) shares, for a total transaction value of $193,028,908.
Got $5,000? 2 Stocks to Buy Now and Hold for the Long Term
11:10am, Sunday, 19'th Oct 2025
Wall Street has long rewarded patience and sound investment choices far more than market timing. Hence, buying and holding stakes in high-quality companies benefiting from powerful secular tailwinds c
Our Top 10 High Growth Dividend Stocks - October 2025
08:00am, Saturday, 18'th Oct 2025
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat
3 Price Catalysts For Eli Lilly
04:26pm, Friday, 17'th Oct 2025
Eli Lilly (NYSE:LLY) is up by ~30% since I last checked on it in August, with further upside potential remaining. Three potential developments can catalyse the stock further to achieve this upside, or
Eli Lilly Makes A Bold Claim For Its Biggest Cancer Drug
08:00am, Friday, 17'th Oct 2025
Eli Lilly said Friday a combination using Verzenio reduced the risk of death by nearly 16% over two years for breast cancer patients.
Lilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment
08:00am, Friday, 17'th Oct 2025
Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk early breast cancer Seven-year results from the
Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?
04:15am, Friday, 17'th Oct 2025
Eli Lilly (LLY -0.97%) and Viking Therapeutics (VKTX -1.02%) offer investors the chance to invest in one of today's highest-potential industries: weight loss drugs. The market for these products, wort
Chesapeake Sells 9,900 Eli Lilly (LLY) Shares Worth $7.7 Million
12:42pm, Thursday, 16'th Oct 2025
Chesapeake Asset Management LLC disclosed in its October 15, 2025, SEC filing the sale of 9,875 Eli Lilly and Company (LLY -0.19%) shares for the quarter ended June 30, 2025. The trade value was an es
How Will Mounjaro and Zepbound Sales Aid Lilly's Upcoming Q3 Results?
10:36am, Thursday, 16'th Oct 2025
Strong demand for Mounjaro and Zepbound is expected to power LLY's Q3 growth, as both drugs deepen U.S. and global market reach.
Lilly confirms date and conference call for third-quarter 2025 financial results announcement
10:00am, Thursday, 16'th Oct 2025
INDIANAPOLIS , Oct. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2025 financial results on October 30, 2025. Lilly will also conduct a conference call tha
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
09:48am, Thursday, 16'th Oct 2025
Investing in pharmaceutical stocks can carry risks. It's not always clear which drugs will be successful and turn into blockbusters for their respective businesses.
How LLY Stock Delivered $47 Billion To Shareholders
09:50am, Wednesday, 15'th Oct 2025
In the last decade, Eli Lilly stock (NYSE: LLY) has returned $47 billion to its shareholders via dividends and buybacks. This shareholder-centric approach has delivered solid results in 2025, with the
In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5, orforglipron lowered A1C by an additional 2.1% when taken with ins
New to Investing? These Are 3 Solid Blue Chip Stocks You Can Build Your Portfolio Around
03:30am, Wednesday, 15'th Oct 2025
Getting started with investing can be overwhelming. There are many solid stocks to choose from, but also many risky ones you'll probably be better off avoiding.
